Sunday 11 October 2026 Export all AZN data to Excel Powerpack

AstraZeneca PLC

AZN Healthcare Drug Manufacturers General

AstraZeneca PLC’s revenue for fiscal 2025 (year ended December 2025) was $58.7 billion, up 8.63% from fiscal 2024. In the quarter to June 2026, revenue grew 6.41%, EPS grew 1.90%, free cash flow fell 107.5% and total debt fell 5.50%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for five; insiders bought in the last twelve months.

159.20 0.42 +0.26%
Market cap
$246.3B
P/E
23.6×
Fwd P/E
23.4×
Dividend yield
2.02%
F-score
9/9
Altman Z
6.26
Beneish M
−2.51
Dividend safety
54/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

21.66% 22.83% 23.47% 21.95%
Piotroski F-Score
7 8 9 8
ROA
8.57% 9.38% 9.43% 9.15%
ROIC
11.65% 12.15% 12.48% 11.67%
Return on Tangible Assets
117.93% 92.38% 102.21% 104.18%
Average Days of Receivables
95.15 101.50 91.58 95.10
Free Cash Flow per Share
6.25 2.84 5.13 4.04
Free Cash Flow
9,691.00 8,819.00 7,939.00 6,265.00
Capital Expenditures
(5,449.00) (5,756.00) (6,282.00) (7,435.00)
Other line items
Cash ROIC
11.40% 10.71% 9.11% 7.38%
Accounts Receivable Turnover
4.05 3.77 4.03 3.94
Accounts Payable Turnover
0.44 0.45 0.49 0.47
Inventory Turnover
1.67 1.80 1.78 1.66
Average Days of Payables
892.11 867.79 742.03 751.43
Days of Inventory on Hand
235.00 225.08 216.63 227.53
Tax Rate
(0.18) (0.17) (0.20) (0.17)
Research and Development Expense of Revenue
25.89% 24.23% 24.10% 24.56%
Selling, General and Administrative Expense of Revenue
35.13% 34.92% 34.66% 35.42%
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Interest Coverage
7.75 8.11 8.24 8.06
Operating CF/Net income
1.61 1.43 1.37 1.31
Depreciation/Fixed assets
0.54 0.44 0.44 0.47
Capex/Depreciation
(0.83) (1.00) (1.08) (1.17)
Revenue per Share
37.48 18.95 39.02 39.57
Operating CF per Share
9.76 4.70 9.18 8.83
Capex per Share
(3.51) (1.86) (4.06) (4.79)
Capex to Sales
0.09 0.10 0.10 0.12

Fold the line items

Columns are period end dates